Inventor

WANG GUOQIANG

CA173 patents

⚠️ This page may combine multiple inventors who share the name “WANG GUOQIANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

WANG GUOQIANG

ENANTA PHARM INC

6-11 bicyclic ketolide derivatives

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

5, 6-D2 uridine nucleoside/tide derivatives

Macrocyclic nucleoside phosphoramidate derivatives

6-11 bicyclic ketolide derivatives

Processes for the preparation of 6-11 bicyclic erythromycin derivatives

6,11-4C-bicyclic 9a-azalide derivatives

6-11 bicyclic ketolide derivatives

6,11-bicyclic erythromycin derivatives

6,11-3C-bicyclic 9a-azalide derivatives

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Heterocyclic compounds as anti-viral agents

Spiropyrrolidine derived antiviral agents

Spiropyrrolidine derived antiviral agents

Spiropyrrolidine derived antiviral agents

Spiropyrrolidine derived antiviral agents

Macrocyclic spiropyrrolidine derived antiviral agents

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Process for preparation of sulfonyl carbamate bile acid derivatives

Tetrazole containing apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Process for preparation of sulfonylurea bile acid derivatives

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Isoxazole analogs as FXR agonists and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Bile acid derivatives as FXR/TGR5 agonists and methods of use thereof

Macrocyclic proline derived HCV serine protease inhibitors

Cyclosporin analogues

Cyclosporin analogues for preventing or treating hepatitis C infection

6-11 Bicyclic erythromycin derivatives

Bicyclic 9a-azalide derivatives

6-11 bridged oxime erythromycin derivatives

6-11 bicycle ketolide derivatives

6,11-4-Carbon bridged ketolides

OR YAT SUN

2′allene-substituted nucleoside derivatives

Macrocyclic proline derived HCV serine protease inhibitors

Cyclosporin analogues

Antiviral agents

FUTUREWEI TECHNOLOGIES INC

Method for scalable routing in content-oriented networks

Multi-tier push service control architecture for large scale conference over ICN

WANG GUOQIANG

2′-chloroacetylenyl substituted nucleoside derivatives

Developing programs for hardware implementation in a graphical specification and constraint language Via iterative estimation of performance or resource utilization

ZHANG XINWEN

Method and apparatus to create and manage a differentiated security framework for content oriented networks

Method and system for secure multiparty cloud computation

RAVINDRAN RAVISHANKAR

Method and apparatus for content identifier based radius constrained cache flooding to enable efficient content routing

UNIV HEFEI TECHNOLOGY

Method and apparatus for joint optimization of multi-UAV task assignment and path planning

NAT INSTR CORP

Optimization of a data flow program based on access pattern information

RAVINDRAN KAUSHIK

Developing programs for hardware implementation in a graphical specification and constraint language